Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase

Published:1999-04 Issue:16 Volume:18 Page:2607-2615
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Elenius Klaus,Choi Caroline J,Paul Subroto,Santiestevan Eric,Nishi Eiichiro,Klagsbrun Michael

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1202612.pdf

Reference55 articles.

1. Auger KR, Serunian LA, Soltoff SP, Libby P and Cantley LC. . 1989 Cell 57: 167–175.

2. Bermingham-McDonough O, McCabe KL and Reh TA. . 1996 Development 122: 1427–1438.

3. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA and Salzer JL. . 1996 Neuron 17: 229–243.

4. Carpenter G and Wahl MI. . 1991 In: Peptide growth factors and their receptors. Sporn MB and Roberts AB. (eds).. Springer-Verlag: New York pp. 69–171.

5. Carraway KL, Weber JL, Unger MJ, Ledesma J, Yu N, Gassmann M and Lai C. . 1997 Nature 387: 512–516.

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer;Frontiers in Physiology;2024-03-27

2. The journey towards physiology and pathology: Tracing the path of neuregulin 4;Genes & Diseases;2024-03

3. HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies;Journal of Thoracic Oncology;2024-01

4. Busting the Breast Cancer with AstraZeneca’s Gefitinib;Advances in Pharmacological and Pharmaceutical Sciences;2023-12-04

5. Cortical wiring by synapse type–specific control of local protein synthesis;Science;2022-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3